VacZine Analytics (United Kingdom)
4 SlideShares
Personal Information
Unternehmen/Arbeitsplatz
London United Kingdom
Beruf
Strategic Research Publisher
Branche
Consulting / Advisory
Webseite
www.vaczine-analytics.com
Info
VacZine Analytics is a strategic research publisher based in the United Kingdom since 2007. We provide high-quality disease and commercial analysis to those working within or in collaboration with the vaccine industry. Our key focus is helping clients build the case for developing new vaccines and immune-based therapies.
Kontaktdetails
Tags
immuno-oncology oncology car-t juno therapeutics kite pharma ctl019 (tisagenlecluecel-t) kymriah cell therapy commercial analysis commercial opportunity assessment prescription pain killers heroin drug addiction opioid crisis new vaccines opioids venclexta btk refractory zydelig ibrutinib market forecast novartis chronic lymphocytic leukemia leukemia axi-cel/kte-c19 non-hodgkins lymphoma allogeneic hematologic stem cell transplants b-all regenerative medicine ctl019 (tisagenlecleucel-t) cancer acute lymphoblastic leukaemia
Mehr anzeigen

Dokumente

(4)
Alle anzeigen

Global market forecast: CAR-T cell therapy in relapsing/recurring Acute Lymphoblastic Leukaemia (ALL)

Vor 6 Jahren • 184 Aufrufe

Global market forecast: CAR-T cell therapy in relapsing/recurring Non-Hodgkin Lymphoma

Vor 6 Jahren • 147 Aufrufe

CAR-T in r/r Chronic Lymphocytic Leukemia global market forecast, size

Vor 6 Jahren • 192 Aufrufe

Vamv078 toc 180201_opioid_use_disorder_vaccines

Vor 6 Jahren • 59 Aufrufe

Gefällt mir

(3)

Current challenges in pertussis prevention gaurav gupta - sept 2016

Gaurav Gupta • Vor 7 Jahren

Update on Pertussis with special reference to QUINVAXEM in India

Gaurav Gupta • Vor 9 Jahren

PERTUSSIS PROTECTION - CURRENT SCHEDULES IN EUROPE

WAidid • Vor 9 Jahren
Personal Information
Unternehmen/Arbeitsplatz
London United Kingdom
Beruf
Strategic Research Publisher
Branche
Consulting / Advisory
Webseite
www.vaczine-analytics.com
Info
VacZine Analytics is a strategic research publisher based in the United Kingdom since 2007. We provide high-quality disease and commercial analysis to those working within or in collaboration with the vaccine industry. Our key focus is helping clients build the case for developing new vaccines and immune-based therapies.
Tags
immuno-oncology oncology car-t juno therapeutics kite pharma ctl019 (tisagenlecluecel-t) kymriah cell therapy commercial analysis commercial opportunity assessment prescription pain killers heroin drug addiction opioid crisis new vaccines opioids venclexta btk refractory zydelig ibrutinib market forecast novartis chronic lymphocytic leukemia leukemia axi-cel/kte-c19 non-hodgkins lymphoma allogeneic hematologic stem cell transplants b-all regenerative medicine ctl019 (tisagenlecleucel-t) cancer acute lymphoblastic leukaemia
Mehr anzeigen